The Politics and PR of Cervical Cancer

The Center for Media and Democracy has completed a four part series of articles, The Politics and PR of Cervical Cancer, about the first FDA approved human papillomavirus (HPV) vaccine GARDASIL,...

Creating A Market For And Testing HPV Vaccines

A quote from the American Cancer Society web site states: Seventy percent (70%) of human papilloma virus (HPV) infections are typically gone within one year and 90% are gone within 2 years. When I read this fact...

Public Health? Profit? What Drives The HPV Vaccination Campaign?

In November 2006, Merck & Co. Inc. began its high pressure saturation 'One Less' campaign for its genetically engineered drug, GARDASIL, being hailed as a tool to prevent cervical cancer caused by two of...

closeSign in to NowPublic

is reporting from